Clinical Trial

The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?

Study acronym: CCP

Active, Not Recruiting

Record status

This record was last updated March 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a 12-month, prospective, observational cohort trial involving Primary Care Trusts (PCTs) wishing to take part in the study and the Early Arthritis Clinic (Anti-CCP sub-clinic) at Chapel Allerton Hospital. The approximate duration of subject participation will be 12 months and the approximate total duration of the study will be 10 years. Patients who have not developed inflammatory arthritis within the 12 month period will have the opportunity to continue follow up within the clinic on an annual basis with additional visits as clinically indicated until the development of IA.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2013-12-10; most recent amendment 2025-03-25.

Status change: Recruiting → Active, Not Recruiting 2025-03-25

Trial Details

NCT Number	NCT02012764
Lead Sponsor	University of Leeds Collaborators: AbbVie
Conditions	Inflammatory Arthritis, Rheumatoid Arthritis
Enrollment	4,000 participants
Start Date	2007-01
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-30